Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Hum Immunol. 2019 Feb 11;80(7):429–436. doi: 10.1016/j.humimm.2019.02.005

Figure 1.

Figure 1

Map of the geographical location of Spain (Spanish territory colored in light yellow and Spanish provinces are delimited by grey borders) which shows the location of the 11 participant clinical laboratories (coded from 1 to 11) in the collection of samples (n=282 healthy unrelated individuals) for this study. In detail: [1] Immunology, Hospital Universitario Marqués de Valdecilla in Santander (n=25 samples); [2] Molecular Biology-Hematology, Hospital Clínico Universitario, in Salamanca (n=26 samples); [3] Immunogenetics and Histocompatibility, Instituto de Investigación Sanitaria Puerta de Hierro in Madrid (n=25 samples); [4] Histocompatibility, Centro de Transfusión de la Comunidad de Madrid in Madrid (n=26 samples); [5] Histocompatibility and Immunogenetics, Banc de Sang i Teixits in Barcelona (n=26 samples); [6] Histocompatibility, Centro de Transfusión de la Comunidad Valenciana in Valencia (n=26 samples); [7] Immunology, Hospital Clínico Universitario Virgen de la Arrixaca in Murcia (n=26 samples); [8] Immunology, Hospital Universitario Reina Sofía in Córdoba (n=26 samples); [9] Immunology, Hospital Universitario Virgen del Rocío in Sevilla (n=25 samples); [10] Histocompatibility, Centro de Transfusión de Málaga in Málaga (n=26 samples) and [11] Immunology, Hospital Universitario de Gran Canaria Dr Negrín in Las Palmas de Gran Canaria (n=25 samples).

*(Maps of this figure are a modified version from http://geology.com/world/map/map-of-spain.gif and from https://desfaziendoentuertos.prepress.es/mapas-de-espana-vectoriales-gratuitos/).